8-K: QT Imaging Announces 3:1 Reverse Split, Nasdaq Relisting Bid

QT Imaging Holdings, Inc. announced a 3:1 reverse stock split to facilitate its application for relisting on the Nasdaq Capital Market.

Summary

• QT Imaging Holdings, Inc. has submitted its application to relist on the Nasdaq Capital Market.
• The Board of Directors approved a 3:1 reverse stock split of the company's issued and outstanding common stock.
• The reverse stock split is intended to fulfill the Nasdaq listing requirement that the common stock must be $4.00 or higher at the time of listing.
• The reverse stock split will become effective at 4:01 p.m. EDT on October 23, 2025.
• Shares of common stock are expected to begin trading on a split-adjusted basis on the OTCQB under the existing symbol "QTIH" on October 24, 2025.
• The new CUSIP number for the common stock following the reverse stock split will be 746962307.
• Every three (3) shares of issued and outstanding common stock will be converted into one (1) share.
• The issued and outstanding shares of common stock will be reduced from 35,671,332 to approximately 11,890,612 shares, subject to all fractional shares being rounded up to the nearest whole share.
• Proportionate adjustments will be made to the exercise prices and number of shares underlying outstanding equity awards and warrants.
• The reverse stock split will not affect the number of authorized shares of common stock.

Sentiment

Score: 7

Explanation: The company is taking proactive steps to improve its market standing by applying for Nasdaq relisting and implementing a reverse stock split to meet listing requirements. This indicates a strategic effort to enhance visibility and attract investors, which is generally positive, despite the inherent negative perception often associated with reverse splits.

Positives

• The company has submitted an application to relist on the Nasdaq Capital Market, which could increase visibility, liquidity, and attract a broader investor base.
• Management views the relisting application and a 'conservative' 3:1 reverse stock split ratio as evidence of business momentum and a strong growth trajectory.
• Moving back to a national exchange is seen as a significant step toward creating long-term stockholder value.
• Fractional shares resulting from the reverse split will be rounded up to the nearest whole share, which is beneficial for shareholders holding fractional amounts.

Negatives

• Reverse stock splits are often perceived negatively by the market as they typically indicate a low stock price and can sometimes be associated with underlying financial challenges.
• The company is currently trading on the OTCQB Venture Market, implying a previous delisting from a major exchange.

Risks

• Research results from the use of the QT Imaging Breast Acoustic CT Scanner may not meet expectations.
• The company's ability to successfully sell and deploy the QT Imaging Breast Acoustic CT Scanner is uncertain.
• Challenges exist in extending product offerings into new areas or products.
• Difficulties may arise in commercializing the company's technology.
• Unexpected occurrences could deter the full documentation and market launch plan for products.
• Trends and fluctuations in the industry could negatively impact the business.
• Changes in demand and purchasing volume from customers pose a risk.
• Unpredictability of suppliers could affect operations.
• The ability to attract and retain qualified personnel is a challenge.
• The company's ability to move product sales to production levels is not guaranteed.

Future Outlook

The company aims to relist on the Nasdaq Capital Market to enhance long-term stockholder value and attract a broader investor base, signaling confidence in its business momentum and growth trajectory.

Management Comments

• "Our application to relist on Nasdaq less than a year after leaving the exchange, coupled with a conservative reverse stock split ratio, is a testament to the exciting momentum and strong growth trajectory in our business." Dr. Raluca Dinu, Chief Executive Officer.
• "Moving back to a national exchange represents a significant step toward creating long-term stockholder value and attracting a broader, more diverse stockholder base." Dr. Raluca Dinu, Chief Executive Officer.

Industry Context

The medical device industry, particularly in innovative imaging systems, often benefits from increased visibility and investor confidence that comes with listing on major exchanges like Nasdaq. A successful relisting could provide QT Imaging with better access to capital and improved market perception, aligning with broader trends of medical technology companies seeking robust funding for R&D and commercialization.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: The number of shares held will decrease by a 3:1 ratio, but the proportionate ownership percentage will remain the same. Fractional shares will be rounded up. There is potential for increased stock price and liquidity if the Nasdaq relisting is successful.
• Employees (holding equity awards): Outstanding equity awards will be proportionately adjusted in terms of exercise prices and the number of underlying shares.
• Warrant Holders: Warrants exercisable for common stock will be proportionately adjusted.

Next Steps

• The Reverse Stock Split will become effective at 4:01 p.m. EDT on October 23, 2025.
• Common Stock is expected to begin trading on the OTCQB on a reverse split-adjusted basis on October 24, 2025.
• The company awaits the outcome of its application to relist on the Nasdaq Capital Market.
• Continental Stock Transfer and Trust Company, the transfer agent, will send letters of transmittal to stockholders holding physical certificates with instructions on how to surrender them.

Key Dates

Recommendation

The company is undertaking a strategic move to relist on Nasdaq, which could improve visibility and liquidity. However, reverse stock splits often carry a negative market perception, and the success of the relisting application is not guaranteed. Investors should hold to observe the outcome of the Nasdaq application and subsequent market reaction, as well as the company's operational performance post-split.

Keywords

QT Imaging, Reverse Stock Split, Nasdaq Relisting, Medical Device, Body Imaging, QTIH, SEC Filing, 8-K